{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T03:25:50Z","timestamp":1790220350273,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":1195,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.bbmt.2011.10.023","type":"journal-article","created":{"date-parts":[[2012,1,9]],"date-time":"2012-01-09T10:48:49Z","timestamp":1326106129000},"page":"S166-S171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"S","title":["Hematopoietic Cell Transplantation for Nonmalignant Disorders"],"prefix":"10.1016","volume":"18","author":[{"given":"Jakub","family":"Tolar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parinda A.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark C.","family":"Walters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2011.10.023_bib1","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jaad.2008.02.004","article-title":"The classification of inherited epidermolysis bullosa (EB): report of the Third International Consensus Meeting on Diagnosis and Classification of EB","volume":"58","author":"Fine","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.bbmt.2011.10.023_bib2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.det.2009.10.020","article-title":"Dystrophic epidermolysis bullosa: pathogenesis and clinical features","volume":"28","author":"Bruckner-Tuderman","year":"2010","journal-title":"Dermatol Clin"},{"issue":"Pt 21","key":"10.1016\/j.bbmt.2011.10.023_bib3","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1242\/jcs.112.21.3641","article-title":"Targeted inactivation of the type VII collagen gene (Col7a1) in mice results in severe blistering phenotype: a model for recessive dystrophic epidermolysis bullosa","volume":"112","author":"Heinonen","year":"1999","journal-title":"J\u00a0Cell Sci"},{"key":"10.1016\/j.bbmt.2011.10.023_bib4","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1182\/blood-2008-06-161299","article-title":"Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells","volume":"113","author":"Tolar","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2011.10.023_bib5","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2353\/ajpath.2008.070977","article-title":"Bone marrow cell transfer into fetal circulation can ameliorate genetic skin diseases by providing fibroblasts to the skin and inducing immune tolerance","volume":"173","author":"Chino","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bbmt.2011.10.023_bib6","doi-asserted-by":"crossref","first-page":"14345","DOI":"10.1073\/pnas.1000044107","article-title":"Bone marrow transplantation restores epidermal basement membrane protein expression and rescues epidermolysis bullosa model mice","volume":"107","author":"Fujita","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbmt.2011.10.023_bib7","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1056\/NEJMoa0910501","article-title":"Bone marrow transplantation for recessive dystrophic epidermolysis bullosa","volume":"363","author":"Wagner","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2011.10.023_bib8","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/stem.647","article-title":"Concise review: transplantation of human hematopoietic cells for extracellular matrix protein deficiency in epidermolysis bullosa","volume":"29","author":"Tolar","year":"2011","journal-title":"Stem Cells"},{"key":"10.1016\/j.bbmt.2011.10.023_bib9","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/j.1365-2133.2010.09981.x","article-title":"Stem cell therapies for recessive dystrophic epidermolysis bullosa","volume":"163","author":"Petrova","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.bbmt.2011.10.023_bib10","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/jid.2010.346","article-title":"Induced pluripotent stem cells from individuals with recessive dystrophic epidermolysis bullosa","volume":"131","author":"Tolar","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.bbmt.2011.10.023_bib11","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/261494a0","article-title":"Susceptibility of Fanconi\u2019s anaemia fibroblasts to chromosome damage by carcinogens","volume":"261","author":"Auerbach","year":"1976","journal-title":"Nature"},{"issue":"suppl 2","key":"10.1016\/j.bbmt.2011.10.023_bib12","first-page":"180","article-title":"Bone marrow transplantation in Fanconi\u2019s anemia","volume":"11","author":"Gluckman","year":"1993","journal-title":"Stem Cells"},{"key":"10.1016\/j.bbmt.2011.10.023_bib13","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1365-2141.2006.06460.x","article-title":"Matched sibling donor haematopoietic stem cell transplantation in Fanconi anaemia: an update of the Cincinnati Children\u2019s experience","volume":"136","author":"Farzin","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2011.10.023_bib14","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/sj.bmt.1701016","article-title":"A fludarabine-based protocol for bone marrow transplantation in Fanconi\u2019s anemia","volume":"20","author":"Kapelushnik","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2011.10.023_bib15","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/pbc.20538","article-title":"Successful engraftment without radiation after fludarabine-based regimen in Fanconi anemia patients undergoing genotypically identical donor hematopoietic cell transplantation","volume":"46","author":"Tan","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.bbmt.2011.10.023_bib16","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1097\/00043426-200311000-00013","article-title":"Low risk of graft-versus-host disease with transplantation of CD34 selected peripheral blood progenitor cells from alternative donors for Fanconi anemia","volume":"25","author":"Boyer","year":"2003","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.bbmt.2011.10.023_bib17","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1365-2141.2007.06975.x","article-title":"Fludarabine-based cytoreductive regimen and T-cell-depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi anaemia","volume":"140","author":"Chaudhury","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2011.10.023_bib18","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2141.2005.05758.x","article-title":"Haematopoietic stem cell transplantation for Shwachman-Diamond disease: a study from the European Group for blood and marrow transplantation","volume":"131","author":"Cesaro","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2011.10.023_bib19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/bmt.2008.151","article-title":"Reduced-intensity conditioning is effective and safe for transplantation of patients with Shwachman-Diamond syndrome","volume":"42","author":"Bhatla","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2011.10.023_bib20","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1046\/j.1365-2141.1996.424984.x","article-title":"Allogeneic marrow transplantation for aplastic anaemia associated with dyskeratosis congenita","volume":"92","author":"Langston","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2011.10.023_bib21","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/bmt.2010.65","article-title":"Disease-specific hematopoietic cell transplantation: nonmyeloablative conditioning regimen for dyskeratosis congenita","volume":"46","author":"Dietz","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2011.10.023_bib22","first-page":"1187","article-title":"Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine","volume":"89","author":"Borgna-Pignatti","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2011.10.023_bib23","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1182\/blood-2009-07-233700","article-title":"Improved survival of children and adolescents with sickle cell disease","volume":"115","author":"Quinn","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2011.10.023_bib24","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/sj.bmt.1703208","article-title":"Allogeneic stem cell transplantation for sickle cell disease. A study of patients\u2019 decisions","volume":"28","author":"van Besien","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2011.10.023_bib25","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1477-7525-3-50","article-title":"Health related quality of life in sickle cell patients: the PiSCES project","volume":"3","author":"McClish","year":"2005","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.bbmt.2011.10.023_bib26","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2174\/156652408786241393","article-title":"Recent advances in bone marrow transplantation in hemoglobinopathies","volume":"8","author":"Michlitsch","year":"2008","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.bbmt.2011.10.023_bib27","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1196\/annals.1345.024","article-title":"Bone marrow transplantation in adults with thalassemia: treatment and long-term follow-up","volume":"1054","author":"Gaziev","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.bbmt.2011.10.023_bib28","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1182\/blood-2003-08-2800","article-title":"New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 years","volume":"104","author":"Sodani","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2011.10.023_bib29","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.bbmt.2007.07.011","article-title":"Status of donor-recipient HLA class I ligands and not the KIR genotype is predictive for the outcome of unrelated hematopoietic stem cell transplantation in beta-thalassemia patients","volume":"13","author":"La Nasa","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2011.10.023_bib30","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1365-2141.2008.07385.x","article-title":"Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in patients with thalassaemia major","volume":"143","author":"Bernardo","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2011.10.023_bib31","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1083-8791(03)00192-7","article-title":"Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia","volume":"9","author":"Iannone","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2011.10.023_bib32","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1056\/NEJMoa0904971","article-title":"Allogeneic hematopoietic stem-cell transplantation for sickle cell disease","volume":"361","author":"Hsieh","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2011.10.023_bib33","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1182\/blood-2002-07-2090","article-title":"Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease","volume":"101","author":"Locatelli","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2011.10.023_bib34","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.bbmt.2011.01.012","article-title":"Umbilical cord blood transplantation for children with thalassemia and sickle cell disease","volume":"17","author":"Ruggeri","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2011.10.023_bib35","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1182\/blood-2009-05-218982","article-title":"Purified T-depleted, CD34+ peripheral blood and bone marrow cell transplantation from haploidentical mother to child with thalassemia","volume":"115","author":"Sodani","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2011.10.023_bib36","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/bmt.2008.203","article-title":"Reduced intensity HLA-haploidentical BMT with post transplantation cyclophosphamide in nonmalignant hematologic diseases","volume":"42","author":"Brodsky","year":"2008","journal-title":"Bone Marrow Transplant"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879111004265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879111004265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:41:36Z","timestamp":1761057696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879111004265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S1083879111004265"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2011.10.023","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hematopoietic Cell Transplantation for Nonmalignant Disorders","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2011.10.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}